---
figid: PMC3677900__pone.0065113.g005
figlink: /pmc/articles/PMC3677900/figure/pone-0065113-g005/
number: Figure 5
caption: Deguelin affects EGFR/c-Met and their downstream target molecules such as
  p-STAT3, p-ERK, p-AKT, c-Myc and Survivin and there by affect growth/survival of
  breast cancer cells. Three different pathways affected by Deguelin are shown by
  different colors; STAT3 (green), AKT (blue), ERK (red). Blue arrows with red outline
  shows molecules shown to be affected by Deguelin in this study. Red dotted line
  indicates possible alternative IL-6 mediated pathway which is not explored in this
  study.
pmcid: PMC3677900
papertitle: Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative
  Breast Cancer Cells.
reftext: Rajeshwari Mehta, et al. PLoS One. 2013;8(6):e65113.
pmc_ranked_result_index: '24842'
pathway_score: 0.926546
filename: pone.0065113.g005.jpg
figtitle: Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative
  Breast Cancer Cells
year: '2013'
organisms: Homo sapiens
ndex: a479d621-df05-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3677900__pone.0065113.g005.html
  '@type': Dataset
  description: Deguelin affects EGFR/c-Met and their downstream target molecules such
    as p-STAT3, p-ERK, p-AKT, c-Myc and Survivin and there by affect growth/survival
    of breast cancer cells. Three different pathways affected by Deguelin are shown
    by different colors; STAT3 (green), AKT (blue), ERK (red). Blue arrows with red
    outline shows molecules shown to be affected by Deguelin in this study. Red dotted
    line indicates possible alternative IL-6 mediated pathway which is not explored
    in this study.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - SLTM
  - MYC
  - RAF1
  - EIF2AK3
  - MAPK3
  - NRAS
  - MAP2K2
  - MAPK1
  - HRAS
  - KRAS
  - PIK3CB
  - EGFR
  - NFKB1
  - BIRC5
  - PIK3R4
  - AKT2
  - AKT3
  - PIK3CG
  - AKT1
  - PIK3R3
  - STAT3
  - IL6
  - TYR
  - HGF
  - PIK3R6
  - PIK3CD
  - MAP2K1
  - PIK3R5
  - PIK3CA
  - Ser
  - Tyr
  - Cancer
  - Lung cancer
genes:
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: c-Met/EGFR/IL-6
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: c-Raf
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: p-ERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: p-ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: p-ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: c-Met/EGFR/IL-6
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Survivin
  symbol: survivin
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: p-STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: (Tyr
  symbol: TYR
  source: hgnc_symbol
  hgnc_symbol: TYR
  entrez: '7299'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
chemicals:
- word: Ser
  source: MESH
  identifier: D012694
- word: Tyr
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
